Health insurance companies: Periodontitis treatment: Switching health insurance companies can be worthwhile

Professional teeth cleaning usually helps with periodontitis. This is not covered by most health insurance companies – but in some cases by some. A comparison is worthwhile.

Periodontitis patients are best looking for a health insurance company that is professional Teeth cleaning generously subsidized. Because this can be useful as part of the treatment.

Periodontitis treatment: costs are often only partially covered

However, it is not in the catalog of benefits of the statutory health insurance companies, like that Consumer advice center North Rhine-Westphalia explained. However, many insurers still cover the costs or subsidize them under certain conditions Teeth cleaning. Patients can find an overview on the website of the National Association of Statutory Health Insurance Dentists by clicking on “Service” and “Information materials”. (dpa)


American jazzman Jimmy Scott dies

American jazz singer Jimmy Scott, known for his soprano voice, has died at age 88, US media reported on Friday. The artist died in his sleep Thursday at his home in Las Vegas, the “Washington Post” said.

James Victor Scott was born in Cleveland, Ohio in 1925 and began his career in the 1940s. He worked with Lionel Hampton, Charlie Parker or Ray Charles.

His work has influenced many musicians, including pop singer Madonna who said, according to the “Washington Post”, that “Jimmy Scott is the only singer who makes me cry”.

Kith presents a collection in collaboration with Oakley, Adidas, Columbia, Tumi, and G-Shock

Kith launches a collection of clothing, footwear and outdoor accessories in collaboration with five marks, entitled ” Element Exploration Agency “. This group includes the labels Oakley, Adidas, Columbia, Tumi, and G-Shock.

Image taken from the video presentation ” The Voyager “, with parts of Oakley and Columbia from the collection Element Exploration Agency – Kith

Among the pieces in the collection, you will find sun glasses Oakley Razor Blades, jackets, pants and tracksuits Columbia, and a canvas bag Tumi with leather details. The color palette draws its inspiration from the red earth of Utah and the blue of the water desperately searching for the traveller. It is shown in the promotional video of the collection, titled The Voyager.

Ronnie Fieg, owner of Kith, has said on Instagram that this collection would include a complete range of products inspired by the fascinating scenery and outdoor sports in Utah.

He presented the collection on the social network with these words : “Working with brands that I admire to create innovative products and revolutionary for the industry has always been my ambition to Kith. “He added that the collection was” thought to bring our aesthetic on new lands and to show the functional side of the principles of Kith. “

Kith has announced the collection with a three-minute video titled The Voyager, that you can view on the site of Columbia. The main character is dressed in a windbreaker and we see him run in the desert of Utah in the manner of a reportage animalier, with a voice-over that comments on his actions with phrases such as ” He can only count on his instincts, his intelligence and his equipment to survive.”

The public use of the territory of Utah became a problem for the sector of outdoor sports. Patagonia has taken the lead of a group of several companies in the textile sector who fight to protect the landscapes that have inspired Kith for its new collection of multi-brand.

However, voices are already to emphasize that the argument of Kith in favor of adventures in the nature in Utah would have had even more impact if the mark was not output the beaten path for his shooting, thereby encouraging good practices in the outdoors in a new group of consumers.

Ronnie Fieg has posted previews of the collection on his account Instagram, but no official launch date has not yet been announced.

All rights of reproduction and representation reserved.
© 2020


Mother’s pass ⋆ Adeba has been around since 1997 and is one of the oldest sites on the topic of wanting children, pregnancy, birth, babies, toddlers and family. With a large forum and lots of privacy.

Independent and neutral. It is a purely private project, which is intended to help many mothers in German-speaking countries.

You can reach us: contact form

Health ⋆ Adeba has been around since 1997 and is one of the oldest sites on the subject of wanting children, pregnancy, birth, babies, toddlers and family. With a large forum and lots of privacy.

Independent and neutral. It is a purely private project, which is intended to help many mothers in German-speaking countries.

You can reach us: contact form

The “Viagra Revolution” celebrates 20 years

A small blue diamond-shaped pill created the sensation twenty years ago: Viagra has made it possible for millions of men to have sexual intercourse again and it has exposed the previously taboo subject of the ‘powerlessness.

But the sexual revolution that followed has abandoned women suffering from dysfunctions and loss of libido, still awaiting them for a miracle cure that would also allow them to find a fulfilling sex life, experts point out.

Some 65 million prescriptions for Viagra, made by the American laboratory Pfizer, have been filled worldwide. It was approved by the Food and Drug Administration (FDA) on March 27, 1998, becoming the first tablet to help men get an erection.

The benefits of this miraculous blockbuster have been touted on TV sets, newspapers, magazines. Its commercialization coincided with the rise of the internet and the explosion of online pornography.

The marketing lexicon has also changed: it is no longer a question of “male impotence” but of “erectile dysfunction”, a medical condition that can now be treated.

Republican Senator Bob Dole, a veteran and presidential candidate in 1996, became his first television ambassador, admitting his own fears to the world.

“It is a little embarrassing for me to speak of ED (for + erectile dysfunction +, editor’s note) but it is so important for millions of men and their partners”, he explained then.

A strategy that worked.

Before Viagra, conversations about erectile problems were “bothersome” and “difficult,” recalls Elizabeth Kavaler, urologist at Lenox Hill Hospital in New York. “Today, sexuality in general is a very present subject”.

It “has become a predictable part of our lives as we age. And I’m sure Viagra has played a big part,” she adds.


For Louis Kavoussi, director of the urology department of the Northwell Health group, Viagra has had a “major impact” similar to that of antibiotics in the treatment of infections or statins in the fight against heart disease.

“It was the perfect medicine to advertise to consumers. It was a kind of lifestyle medicine,” he said.

Viagra, or sildenafil citrate, has been developed to treat high blood pressure and angina. But from the first clinical trials, men quickly discovered an unexpected effect: the improvement of their erections.

From fifteen dollars a unit at the start, the price swelled to more than 50 dollars. With the release of a generic version last year, the price fell to a dollar a penny.

In 2000, the famous comic show Saturday Night Live even dedicated a sketch to him with actor Christopher Walken parodying an advertisement.

“We are a very Puritan society and I think Viagra has relaxed us a bit,” said Nachum Katlowitz, director of the urology and fertility department at Staten Island University Hospital. But “women have been left out of the sexual improvement revolution.”

The FDA approved in 2015 flibanserin – marketed in the United States under the name Addyi–, qualified as “female Viagra” and presented as a treatment to revive the libido of women. But from its launch, it caused controversy.

Because Addyi belongs to the family of antidepressants, women are advised not to consume alcohol at the same time. It also costs several hundred dollars and can cause significant side effects (nausea, vomiting, suicidal thoughts, etc.).

“It didn’t work very well,” says Katlowitz.

The problem in women comes mainly from vaginal dryness at the time of menopause, which can make intercourse painful.

According to Elizabeth Kavaler, taking hormones or even laser treatments can provide solutions that are, despite their sometimes very high cost, increasingly popular.

“We are at least twenty years behind men,” she said.

With AFP


Own Cancer Fuels Doctor’s Quest for Cure | Health | News | The sun

It was in 2005: the young oncologist surgeon had just had his right eye removed because of ocular melanoma, a rare cancer that affects six out of a million people on average in the United States.

Prior to this procedure, her doctors were confident in her ability to make a full recovery and have the surgery again.

“But my reality, with the loss of my eye, was that my perception of depth had been destabilized,” he told AFP. “I knew I could no longer operate.”

At the time, he was 33 years old and had just spent thirteen training and practicing cancer surgery, a specialty he chose before he even knew he would suffer from cancer himself. He was also interested in research on this disease.

But after his eye was removed, he didn’t feel out of place anywhere.

“I was a surgeon who could not operate and I was interested in oncology, but I was not a doctor of internal medicine,” recalls Hinrichs, who therefore returned to school for four years to acquire these skills.

A return to square one for this thirty-something, married and young father.

But with one goal in mind that has become a personal struggle: to find a way to beat cancer when surgery, chemotherapy and radiation therapy fail.

In the event of recurrence, “I would be in the group of incurable patients”, loose the 46-year-old doctor, specifying that his cancer would then be considered metastatic and therefore fatal.


Now a researcher at the National Cancer Institute, he is leading trials to eradicate cancers caused by the papillomavirus (HPV), a sexually transmitted virus that causes various cancers such as that of the cervix or throat.

Two women who participated in the first clinical trials of immunotherapy against cervical cancer are considered cured because they have not had any trace of the disease for at least five years.

These trials, conducted at the National Institutes of Health Clinical Center, the most prestigious establishment in the United States in terms of research, involve patients with advanced stage cancers who no longer respond to conventional treatments.

If the majority of them did not heal at the end of Dr. Hinrichs’ tests, some nevertheless saw their cancer disappear within a few months. The hope is to design new treatments one day accessible to the general public.

His colleagues describe him as straightforward, honest and blunt, “with a sense of urgency to advance his research” possibly linked to his own experience of the disease. An experience that also brings him closer to his patients.

Aricca Wallace, one of the two healed patients, describes her “scanxiety” – her anxiety with every monitoring MRI (“scan”) – which the doctor helps her overcome. According to her, they have more “a family relationship than doctor-patient”.

The oncologist stopped taking control scans (MRI and X-ray) about five years after his eye was removed. The risk of recurrence for this type of tumor is approximately 50%.

“The statistics are really of limited value” in this case, he explains.

The doctor does not see himself doing anything other than research, to find a cure for advanced cancers by practicing a single injection of billions of lymphocytes, taken from the patient and cultivated so that they multiply. An immune invasion against cancer.

“People with cancer don’t want researchers who focus on things that slow cancer down or have limited effects,” he says.

And to say: “What they really want is for their cancer to disappear”.


Cancer immunotherapy progresses

Sue Scott had already organized her funeral. It was the winter of 2013, she was 36 years old and her cervical cancer was metastasizing at top speed.

Chemotherapy, radiotherapy, operations … everything had failed. The tumors were now lodged in his liver and colon. But Sue got one last chance: an experimental trial at the clinical center of the National Institutes of Health.

At this publicly funded research hospital, doctors were trying to replace patients’ immune systems with lymphocytes (white blood cells) programmed to specifically attack cancers related to papillomavirus (HPV), a sexually transmitted and widespread virus.

A few months later … Sue’s tumors were completely gone. In March, she celebrated five years of complete remission. Doctors consider her to be cured.

“My greatest reward is being a source of hope for other people,” says the real estate agent in Washington, who also volunteers for cancer patients.

The clinical trial in which she participated is a breakthrough in the fight against cancer. This is the first time that researchers have shown that immunotherapy, already effective against blood and skin cancer, can also be used successfully against cancer of the cervix.

What’s more, Sue’s recovery led doctors to an unexpected discovery, which could kill other types of tumors. Doctor Christian Hinrichs, from the National Cancer Institute, told him the good news in February during a check-up.

“We got a certain genetic sequence from you, which we can put into anyone’s cells to attack cancer the same way,” Hinrichs explains. “We’re trying to see if it works clinically.”

A survivor doctor

Dr Hinrichs, 46, himself is a survivor of a particularly rare cancer, which affects six in a million people.

When he was in his twenties, the young surgeon learned he had melanoma in his right eye. But after each laser or radiotherapy treatment, the cancer would come back. He had to resolve to have his eye removed in 2005.

“I am influenced in my research by the fact of having known cancer myself and the fear that it will come back every time”, specifies the researcher to AFP. “I really wanted to find a treatment to prevent the cancer from coming back.”

The purpose of white blood cells is to attack intruders. But when the intruder is a tumor capable of mutating, hiding, or growing on such a scale that it overwhelms the immune system, lymphocytes often fail.

Immunotherapy is believed to solve this problem. It works well against cancers of the blood, like lymphoma or leukemia, because in these cases the cancers carry some kind of flag or signal on their surface (antigens of the tumor), which makes them easily spotted.

But most cancers don’t have this “flag”.

In Sue’s case, the cancer carried HPV antigens – a signal that the immune system can recognize.

“This cancer is very interesting because the virus is right in the middle,” says Miriam Merad, professor of oncology at Icahn School of Medicine in Mount Sinai, New York.

Dr. Hinrichs’ work, she says, is “absolutely crucial” to understanding why immunotherapy works in some people and not others … which remains a mystery. Still to develop new clinical trials to confirm the breakthrough.

A suprise

For Sue, here’s how the doctors proceeded: They operated to remove one of her tumors, then they isolated the lymphocytes that were attacking her.

The researchers then “cultivated” these lymphocytes, and produced billions more, which they then reinjected into his blood … causing a real immune invasion.

This treatment was successful in another patient, a 41-year-old mother, Aricca Wallace, living in Kansas City. She too is considered cured after five years without a tumor.

But the trial failed in the sixteen other women who participated.

Looking at the data from the two recovered patients, Hinrichs found that two-thirds of the cells that eradicated Sue’s cancer attacked another signal or flag, the KK-LC-1 protein.

However, this protein is also expressed in cancers that affect half a million people around the world, in particular one of the most fatal breast cancers, as well as certain cancers of the stomach. Doctors had therefore found their new target.

“It was a hell of a surprise,” recalls the doctor. “It reminds us that science sometimes takes us in directions different from those we had anticipated.”

The next step is therefore to launch clinical trials to treat cancers where this famous KK-LC-1 protein is expressed, in about a year. International patients can apply to participate.

Nothing guarantees success, but the approach is “promising”, told AFP Ronald Gress, deputy director of the National Cancer Institute. “It is one of the most amazing options, but at the same time it is an option that could really help patients.”

Sue, for her part, cannot believe that her cells may one day be able to cure other patients.

“Are you telling me that I have something in me that can help others?” It’s pretty crazy, ”she rejoices.

After the rampage in Florida – The face of the protest against the gun lobby (archive)

Emma Gonzalez, 18 years old, Cuban, graduating from Stoneman Douglas High School. A passionate speech made her THE face of the protest:

“Politicians who sit in their gilded houses and chairs that are paid for by the gun lobby NRA tell us: Nothing could have prevented something like this … we say: bullshit.”

Again and again she resolutely wipes the tears from her eyes. That was three days after the school rampage that killed 17 people. The schoolgirl Emma Gonzalez suddenly became the activist Emma Gonzalez. Painting, drawing, sewing – all of her hobbies have suddenly become unimportant. Because the young woman with the shaved hair has only one goal: to change the gun laws in her country. She believes Trump’s proposal to arm teachers is completely wrong:

“My school had two weeks every year when they ran out of paper. And now there is supposed to be $ 400 million to train teachers on the gun? Really? Really now?”

More followers than the gun lobby NRA

She doesn’t talk about it for long. She criticizes, accuses, demands. She now has more followers on Twitter than the powerful gun lobby NRA. Many stand behind Emma. Others attack them. When a Republican politician, who actually had no opponent in the election campaign in Maine, cursed Emma as a skinhead lesbian, a 28-year-old decides to run against him. In the meantime the man has given up.

And Emma? Just keep going. Her mother Beth watches the rapid development in amazement and a little worried, she says on CBS:

“I’m scared. It’s like she’s built wings out of wood and duct tape and throws herself off a building. We run under her with a rescue net that she doesn’t want or that she thinks she doesn’t need.”

Activism instead of learning

Emma’s form of mourning: protesting, shaking up. Your life is upside down. If the massacre hadn’t happened, she’d just be studying to graduate now. Emma was born in the year of the rampage at Columbine High School in Colorado:

“I no no world without mass shootings in schools.”

But Emma and her classmates want to ensure that the students who come after her can go to school again without fear. She has been living for this since February 14th.

Côte d’Ivoire / International / Researchers discover new genetic disease that makes influenza very dangerous

A nurse examines a young patient at a Beijing hospital on January 11, 2018 (XINHUA / AFP)

Abidjan, March 23 (AIP) – Researchers announced on Thursday that they had discovered a gene whose mutations can turn a simple flu into a life-threatening infection. “It is therefore a new genetic disease of immunity that has been identified”, explained in a press release the Parisian genetic research institute Imagine. “This results in an extreme vulnerability to viral infections which are usually not serious, with damage precisely localized to the brainstem”, add the researchers. The gene in question, called DBR1, makes us unequal in the face of common viruses in our environment: influenza, norovirus (which causes gastroenteritis) and …

Unless authorized by the editorial staff or pre-established partnership, the resumption of articles from AIP.CI, even partial, is strictly prohibited. Violators may be subject to prosecution.

Please log in to read the full story.


Swiss researchers are developing alternative antibiotics

After the World Health Organization (WHO) and the Federal Minister of Health Hermann Gröhe (CDU) have been warning about the increasing resistance of germs to antibiotics for some time now, researchers from Switzerland have now made a small breakthrough regarding future treatments for bacterial infections. The international research team under Swiss leadership has developed a substance that could be used as an alternative to antibiotics in the near future.

Antibiotic-resistant bacteria Image: Mkaercher CC BY-SA 3.0 (VIA WIKIMEDIA COMMONS)

New substance promises help against ineffectiveness of antibiotics

Eduard Babiychuk and Annette Draeger from the Institute of Anatomy at the University of Bern took over the management of the research on the novel antibiotic alternative.

We created an irresistible bait for bacterial toxins. For this reason, they attack the liposomes and are captured there and made harmless without harming our body cells. Eduard Babiychuk told the SDA news agency.

The study was published in the trade journal “Nature Biotechnology”, among others. Every year in Germany alone, 15,000 people die from diseases caused by bacteria that could no longer be successfully treated with antibiotics due to resistance. The ineffectiveness of antibiotics continues to increase. Alternatives are in demand than ever. Experts accuse doctors in particular of prescribing antibiotics too quickly. The drug is often recommended even though there is a virus infection. Antibiotics against viruses are known to be useless. A rapid rethink must therefore take place here.

Patent application and first studies

According to the latest findings, the researchers have succeeded in establishing a kind of protective shield for the cells using liposomes. The shield intercepts the toxins expelled by bacteria. The new active ingredient was filed with the patent office by the technology transfer organization Unitectra Bern. Subsequently, clinical studies with the new antibiotic alternative are to be carried out. Long-term studies are also still required. The active ingredient is also manufactured and developed by the Geneva biotech company Lascco.

A trusted clinical trial is about to start an initial clinical trial. The aim is to treat patients suffering from severe pneumonia, which in turn is caused by streptococci. The results are eagerly awaited. If the new active ingredient prevails, the researchers would first have found a solution to the fight against antibiotic-resistant infections.

Share the article or support us with a donation.
PayPal donationAmazon donation shopping